AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance. - Tregunno C; Deraedt Q; Cuadripani S; Verheust C; Bryan P (Drug safety, 2026)